Clinical course in sarcoidosis patients presenting with cutaneous involvement may be similar to patients without cutaneous involvement
PDF
Cite
Share
Request
Original Article
P: 112-116
December 2022

Clinical course in sarcoidosis patients presenting with cutaneous involvement may be similar to patients without cutaneous involvement

J Turk Soc Rheumatol 2022;14(3):112-116
1. Sağlık Bilimleri Üniversitesi, Kartal Dr. Lütfi Kırdar Şehir Hastanesi, İç Hastalıkları Kliniği, Romatoloji Bölümü, İstanbul, Türkiye
2. Sağlık Bilimleri Üniversitesi, Süreyyapaşa Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İstanbul, Türkiye
3. Sağlık Bilimleri Üniversitesi, Kartal Dr. Lütfi Kırdar Şehir Hastanesi, İç Hastalıkları Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 07.05.2022
Accepted Date: 14.09.2022
Publish Date: 27.12.2022
PDF
Cite
Share
Request

ABSTRACT

Objective:

Patients with sarcoidosis may present with cutaneous lesions or other systemic involvement, particularly pulmonary. In this study, we investigated our hypothesis that the clinical course of sarcoidosis patients who present with skin involvement be different.

Methods:

Fifty-two sarcoidosis patients who applied to our rheumatology outpatient clinic were included in the study. Data on demographics, smoking status, angiotensin converting enzyme (ACE) level at the time of diagnosis, other organ involvement and lung involvement stages were collected. We then compared the clinical and demographic characteristics of patients with and without skin involvement and patients with skin involvement at first presentation, and others separately.

Results:

While the initial involvement was lung involvement in 28 (53.5%) patients, 19 (36.5%) patients applied to the clinic with skin involvement as a presenting feature. In 23 (44.2%) patients, skin involvement was present at any time during the disease. In our study, the most common skin involvement was erythema nodosum observed in 9 patients (17.3%). Demographic and clinical findings of patients presenting with skin findings did not differ significantly from other patients. High ACE levels were more common in patients without skin involvement than in patients with skin involvement.

Conclusion:

Even if the clinical course does not differ in sarcoidosis patients presenting with cutaneous involvement, it is important to recognize the cutaneous manifestations of sarcoidosis. We would like to emphasize that detailed physical examination is important, as easily overlooked, small and asymptomatic lesions are the most appropriate site for histopathological diagnosis of sarcoidosis.

References

1Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and Management of Sarcoidosis. Am Fam Physician 2016;93:840-8.
2Llanos O, Hamzeh N. Sarcoidosis. Med Clin North Am 2019;103:527-34.
3Al-Kofahi K, Korsten P, Ascoli C, et al. Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag 2016;12:1623-34.
4Yanardag H, Tetikkurt C, Bilir M, Demirci S, Iscimen A. Diagnosis of cutaneous sarcoidosis; clinical and the prognostic significance of skin lesions. Multidiscip Respir Med 2013;8:26.
5Sève P, Pacheco Y, Durupt F, et al. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells 2021;10:766.
6Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl 2001;32:56s-68s.
7Dikicier BS. Cutaneous Sarcoidosis. Güncel Dermatoloji Dergisi 2018;3:33-43.
8Caplan A, Rosenbach M, Imadojemu S. Cutaneous Sarcoidosis. Semin Respir Crit Care Med 2020;41:689-99.
9Mert A. Eritema Nodozum: 9 yıllık Deneyim. Cerrahpaşa Tıp Dergisi 2002;33:47-59.
10Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J Am Acad Dermatol 2006;54:55-60.
11Grunewald J, Eklund A. Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 2009;179:307-12.
12Marcoval J, Mana J, Rubio M. Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease. Clin Exp Dermatol 2011;36:739-44.
13Meyer-Gonzalez T, Suarez-Perez JA, Lopez-Navarro N, Hidalgo A, Herrera-Ceballos E. Subcutaneous sarcoidosis: a predictor of systemic disease? Eur J Intern Med 2011;22:e162-3.
14Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease. J Am Acad Dermatol 2012;66:719 e1-10; quiz 29-30.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House